STADA Arzneimittel AG

Explore STADA

As a pharmaceutical and healthcare company, STADA is responsible for ensuring the group-wide safety of its products and thus also the safety of patients. That’s what SDG 17 is all about.

Diversity & Inclusion

Our culture thrives on empowering our people to bring forward their unique and diverse experiences. Thought leadership article by Simone Berger, CPO.

Trusted Partner

Central to STADA's commitment to caring for people's health through consumer healthcare products, specialty medicines and generics are close partnerships to improve health globally.

Culture

Our employees drive STADA’s growth culture. This is energized by the actions of our people every day to bring health to society as One STADA team. Read the #InternationalMobility story of Fatimah Sajjadi.

STADA Health Report

More than 3 in 4 Europeans would undergo genetic testing if advised by their doctor.
Our representative survey in 23 countries show that the healthcare system no longer adequately addresses the needs of many Europeans, causing them to take charge of their own health.

Three-pillar Strategy

The company focuses on consumer healthcare products, generics and speciality medicines.

Your opportunity for success with STADA

We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.

Careers at STADA

Growth mindset: Our people are our ambassadors

2024 Closing!

By Florian Kropf,

Happy to share the list of books that made me think and call to action in 2024!

By Mar Fabregas, Head of Iberia & General Manager, STADA Spain

By Florence Masson, Marketing and External Communication Manager at EG LABO

💚 ALIUD coat sponsorship: support for budding pharmacists 💚

By Delia Heeger-Heß,

New Silomat TV advert - Cough, experience your blue wonder! 💙

By Julia Döpfner,

Florence Masson on LinkedIn

Marketing and External Communication Manager, EG LABO

23 December 2024

✔ International events with exceptional colleagues who allowed me to exchange and build ideas with industry experts,
✔ Collaborative and ambitious projects with our partners to open new opportunities,
✔ Launches of innovative products to meet patient needs and fully accomplish our mission,
✔ Inspiring workshops and initiatives that allowed us to co-create innovative solutions and stimulate our collective thinking...
🌟 What I take away:
Beyond the numbers and results, it’s the human connections, creativity, and shared passion that make all the difference. This year was marked by incredible energy, challenges successfully met, and above all, enriching collaboration with passionate and talented people.
Thank you to everyone I had the chance to collaborate with in 2024 🙏
I wish you all wonderful end-of-year celebrations🎄

✨ Tirer le meilleur de 2024 !✨

Alors que l’année 2024 touche à sa fin, c’est avec beaucoup de gratitude et fierté que je souhaite revenir sur quelques-uns des moments forts qui ont marqué cette année professionnelle riche et passionnante !

✔ Des évènements internationaux, avec des collègues exceptionnels qui m’ont permis d’échanger et de bâtir des idées avec des experts du secteur,
✔ Des projets collaboratifs et ambitieux avec nos partenaires pour ouvrir de nouvelles opportunités,
✔ Des lancements de produits innovants pour répondre aux besoins des patients et remplir pleinement notre mission,
✔ Des workshops et initiatives inspirantes qui ont permis de co-construire des solutions innovantes et stimuler notre réflexion collective …

🌟 Ce que je retiens :
Au-delà des chiffres et des résultats, ce sont les relations humaines, la créativité, et la passion partagée qui font toute la différence. Cette année a été marquée par une énergie incroyable, des défis relevés avec succès, et surtout, par une collaboration enrichissante avec des personnes passionnées et talentueuses.
Merci à toutes les personnes avec qui j’ai eu la chance de collaborer en 2024 🙏
Je vous souhaite de très belles fêtes de fin d’année 🎄

🚀 Cap sur 2025 !
Avec l’envie de continuer à apprendre, à innover, et à partager, je suis impatiente de voir ce que 2025 nous réserve !

OneSTADA Gratitude Capsur2025

View on LinkedIn

STADA Voices

Miguel Pagan Fernandez

Frank Staud

Volker Sydow

Stéphane Jacqmin

Dr. Christoph Dengler

Christos Gallis

Sustainability Stories

Latest news

04/12/2024

STADA welcomes Ingo Schachel as Head of Investor Relations

31/10/2024

New STADA facility in Romania for sustainable medicines supply in Europe

10/10/2024

EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar

28/08/2024

STADA continues strong growth journey in the first half of 2024

26/07/2024

European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine

22/07/2024

STADA launches ustekinumab biosimilar in Europe

24/06/2024

STADA Health Report 2024: Satisfaction with healthcare systems continues to decline

11/06/2024

Alvotech and STADA add to strategic alliance through denosumab partnership

28/05/2024

Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, EU and UK

21/05/2024

STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey

10/05/2024

Xbrane, STADA partner with Valorum Biologics to commercialize ranibizumab biosimilar candidate in the US

14/03/2024

STADA continues with double-digit sales and profit growth in 2023

10/01/2024

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

09/01/2024

Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

Read our news

Consumer Healthcare products

STADA is the fourth-largest consumer healthcare company in Europe and markets products internationally in all relevant healthcare categories. The most significant drivers are the Local Hero Brands, strong regional brands and newly acquired products that successfully complement the existing product range.

View our brands

Improving access to life-changing treatments for patients worldwide

Specialty Pharmaceuticals are medicines, that give patients access to innovative treatment options, especially for chronic, severe or rare diseases.

STADA’s Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions.

Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People’s Health as a Trusted Partner”.

Specialty Pharmaceuticals

Affordable generics have been the backbone of STADA since 1895

As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales.

Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure.

Generics

Our purpose is ‘Caring for People’s Health as a Trusted Partner’

At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business –

and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty.

Our purpose